# International Flavors & Fragrances Inc: overview

IFF · NYSE · CIK 51253 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/iff.md) · [Financials](/companies/iff/financials.md) · [Filings](/companies/iff/filings.md) · [Insiders](/companies/iff/insiders.md)

Latest reported revenue: [$1.95bn](/filings/0000051253-26-000030.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 4, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0000051253-26-000030).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [2,925](/filings/0000051253-26-000006.md) | [2,771](/filings/0000051253-26-000006.md) | [2,843](/filings/0000051253-26-000017.md) | [1,919](/filings/0000051253-26-000030.md) | [2,694](/filings/0000051253-25-000049.md) | [2,589 d](/filings/0000051253-26-000006.md) | [2,741](/filings/0000051253-26-000017.md) | [1,954](/filings/0000051253-26-000030.md) |
| Gross margin | % | [36.0%](/filings/0000051253-26-000006.md) | [35.4%](/filings/0000051253-26-000006.md) | [36.4%](/filings/0000051253-26-000017.md) | [42.9%](/filings/0000051253-26-000030.md) | [36.5%](/filings/0000051253-25-000049.md) | [34.4% d](/filings/0000051253-26-000006.md) | [37.1%](/filings/0000051253-26-000017.md) | [43.7%](/filings/0000051253-26-000030.md) |
| Operating margin | % | [8.5%](/filings/0000051253-25-000049.md) | [4.6% d](/filings/0000051253-26-000006.md) | [(31.8%)](/filings/0000051253-26-000017.md) | [7.4%](/filings/0000051253-26-000030.md) | [8.4%](/filings/0000051253-25-000049.md) | [3.7% d](/filings/0000051253-26-000006.md) | [10.0%](/filings/0000051253-26-000017.md) | [8.1%](/filings/0000051253-26-000030.md) |
| Net margin | % | [2.0%](/filings/0000051253-25-000049.md) | [(2.0%) d](/filings/0000051253-26-000006.md) | [(35.8%)](/filings/0000051253-26-000017.md) | [31.2%](/filings/0000051253-26-000030.md) | [1.5%](/filings/0000051253-25-000049.md) | [1.3% d](/filings/0000051253-26-000006.md) | [6.2%](/filings/0000051253-26-000017.md) | [2.6%](/filings/0000051253-26-000030.md) |
| Diluted EPS | $ per share | [0.23](/filings/0000051253-25-000049.md) | not reported | [(3.98)](/filings/0000051253-26-000017.md) | [2.33](/filings/0000051253-26-000030.md) | [0.16](/filings/0000051253-25-000049.md) | not reported | [0.66](/filings/0000051253-26-000017.md) | [0.20](/filings/0000051253-26-000030.md) |
| Free cash flow | $m | [242 d](/filings/0000051253-25-000049.md) | [229 d](/filings/0000051253-26-000006.md) | [(52.0)](/filings/0000051253-26-000017.md) | [146 d](/filings/0000051253-26-000030.md) | [32.0 d](/filings/0000051253-25-000049.md) | [130 d](/filings/0000051253-26-000006.md) | [92.0](/filings/0000051253-26-000017.md) | [286 d](/filings/0000051253-26-000030.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax; Net income: us-gaap:ProfitLoss. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [11.7](/filings/0000051253-24-000006.md) | [12.4](/filings/0000051253-25-000013.md) | [11.5](/filings/0000051253-26-000006.md) | [11.5](/filings/0000051253-26-000006.md) | [10.9](/filings/0000051253-26-000006.md) |
| Gross margin | % | [32.0%](/filings/0000051253-24-000006.md) | [33.4%](/filings/0000051253-25-000013.md) | [32.1%](/filings/0000051253-26-000006.md) | [35.9%](/filings/0000051253-26-000006.md) | [36.2%](/filings/0000051253-26-000006.md) |
| Operating margin | % | [5.0%](/filings/0000051253-24-000006.md) | [(10.7%)](/filings/0000051253-25-000013.md) | [(18.4%)](/filings/0000051253-26-000006.md) | [6.7%](/filings/0000051253-26-000006.md) | [(3.5%)](/filings/0000051253-26-000006.md) |
| Net margin | % | [2.4%](/filings/0000051253-24-000006.md) | [(15.0%)](/filings/0000051253-25-000013.md) | [(22.5%)](/filings/0000051253-26-000006.md) | [2.3%](/filings/0000051253-26-000006.md) | [(3.3%)](/filings/0000051253-26-000006.md) |
| Diluted EPS | $ per share | [1.10](/filings/0000051253-24-000006.md) | [(7.32)](/filings/0000051253-25-000013.md) | [(10.14)](/filings/0000051253-26-000006.md) | [1.04](/filings/0000051253-26-000006.md) | [(1.41)](/filings/0000051253-26-000006.md) |
| Free cash flow | $bn | [1.0](/filings/0000051253-24-000006.md) | [(0.1)](/filings/0000051253-25-000013.md) | [1.0](/filings/0000051253-26-000006.md) | [0.6](/filings/0000051253-26-000006.md) | [0.3](/filings/0000051253-26-000006.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:ProfitLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/iff/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [Dodge & Cox](/funds/200217.md) | 2026-06-30 | $2.93bn | 37,007,037 |  | Added +534,095 |
| [Freemont Capital Pte Ltd](/funds/1796107.md) | 2026-06-30 | $2.01bn | 25,356,381 |  | Unchanged |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $1.84bn | 23,175,401 |  | Added +454,108 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $1.29bn | 16,255,207 |  | Added +16,982 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $982.4m | 12,340,998 |  | Added +1,053,044 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $919.6m | 11,608,686 |  | Reduced −114,545 |
| [First Eagle Investment Management, LLC](/funds/1325447.md) | 2026-06-30 | $745.4m | 9,409,698 |  | Added +95,028 |
| [First Eagle Investment Management, LLC](/funds/1325447.md) | 2026-06-30 | $745.4m | 9,409,698 |  | Added +95,028 |
| [Invesco Ltd.](/funds/914208.md) | 2026-06-30 | $744.9m | 9,403,330 |  | Added +1,910,489 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $537.6m | 6,812,731 |  | Reduced −144,460 |

## Recent filings

[All 3,369 filings](/companies/iff/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-04 | 16:40 ET | [8-K](/filings/0000051253-26-000032.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000051253-26-000032 |
| 2026-08-04 | 16:34 ET | [10-Q](/filings/0000051253-26-000030.md) | Quarterly report, period 2026-06-30 | 0000051253-26-000030 |
| 2026-08-04 | 16:24 ET | [8-K](/filings/0000051253-26-000028.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0000051253-26-000028 |
| 2026-06-23 | 16:39 ET | [8-K](/filings/0001140361-26-026107.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001140361-26-026107 |
| 2026-06-01 | 09:00 ET | [8-K](/filings/0001193125-26-249963.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-249963 |
| 2026-05-05 | 16:24 ET | [10-Q](/filings/0000051253-26-000017.md) | Quarterly report, period 2026-03-31 | 0000051253-26-000017 |
| 2026-05-05 | 16:17 ET | [8-K](/filings/0000051253-26-000015.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000051253-26-000015 |
| 2026-05-04 | 17:06 ET | [8-K](/filings/0001140361-26-018910.md) | 5.07 Shareholder vote results | 0001140361-26-018910 |
| 2026-03-18 | 08:00 ET | [DEF 14A](/filings/0001140361-26-009960.md) | Proxy statement, period 2026-04-29 | 0001140361-26-009960 |
| 2026-02-27 | 17:16 ET | [10-K](/filings/0000051253-26-000006.md) | Annual report, period 2025-12-31 | 0000051253-26-000006 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0000051253-26-000006.md), filed Feb 27, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/c17a2e16-ade6-4c81-965d-af3a5145ab21)

## About the filer

- CIK: 51253
- Tickers: IFF
- Exchange: NYSE
- SIC code: 2860 Industrial Organic Chemicals
- State of incorporation: NY
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:19 ET. No prices; not investment advice.